[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Soliciting Bakari's input on drug resistance
- From: "Rachel Nugent" <RNugent@cgdev.org>
- Date: Tue, 3 Jun 2008 09:29:58 -0400
E-DRUG: Soliciting Bakari's input on drug resistance
-----------------------------------------
Bakari very accurately and eloquently describes several of the current
global drug supply chain management challenges which, alongside many
others, we, at the Center for Global Development's Drug Resistance
Working Group (see http://www.cgdev.org/drug_resistance), are seeking to
tackle.
The DRWG seeks to motivate changes in the policies and practices of
global actors that would reduce the drug resistance affecting
high-burden diseases in developing countries, primarily by:
1. Communicating the evidence that drug resistance is an important
global policy priority and articulating a common solution framework
based on the factors driving resistance across diseases;
2. Bringing together and building momentum around the issue among key
global stakeholders across sectors;
3. Identifying core areas for intervention and discussing the set of
incentives, governance capabilities and actions, and financing
mechanisms that could plausibly move the world forward together in the
right direction; and
4. Supporting the launch of (but not directly implementing) immediate
next steps to correct underlying institutional weaknesses and misaligned
incentives and have long-term impact across all diseases and products.
One key component of our ongoing work program is development of a
background paper examining risks and incentives facing different actors
in the product value chain, and testing the implications of changing
incentives through modeling and qualitative research. This paper will
also attempt to address the impediments to past recommendations, seeking
to highlight challenges to implementation of these recommendations and
determining what incentives at which point might have led to larger
impact. As this work moves forward, it will be shared virtually, both
through our website and through a monthly e-newsletter dedicated to drug
resistance and global health (to subscribe, please visit
https://secure2.convio.net/cgdev/site/SPageServer?pagename=register).
We welcome your thoughts and input!
Rachel Nugent
Senior Program Associate for Global Health
Center for Global Development
rnugent@cgdev.org
|